Africa's Diagnostics Crisis Demands Emergency Action
The 2026 African Union Summit concluded with a focus on health financing, local manufacturing, and global health reform, yet the gap between policy declarations and practical diagnostics in rural clinics across Africa remains vast. High-level meetings often articulate problems without delivering tangible solutions, leaving communities in dire need.
The Stark Reality of Diagnostic Gaps
Reports highlight a critical global issue: nearly half the world's population has limited access to diagnostics, leading to over a million preventable deaths annually in low- and middle-income countries. In Africa, progress is slowest in areas requiring substantial resources, such as workforce development and affordability. The 2025 Global Diagnostics Gap Assessment identifies systemic barriers like underinvestment and delayed data access, underscoring that these are not mere technical challenges but deep-seated failures.
Historical Declarations and Current Failures
Africa has not been idle; initiatives like the 2008 Maputo Declaration and the Lusaka Agenda advocate for quality laboratory services and domestic health financing. However, daily realities tell a different story. In the WHO African Region, 40% of countries lack medical device regulations, and 60% do not have essential diagnostics lists meeting WHO standards. This disconnect means that a mother with a febrile child at a primary health clinic often finds no rapid test available, forcing clinicians to make incorrect presumptive diagnoses.
Political and Financial Imperatives
Health sovereignty requires more than slogans; it demands budget allocations backed by law. Many African countries allocate only 4% of their national budgets to health, far below the 15% pledged in Abuja. Essential diagnostics lists remain unoperationalized at facility levels, highlighting a lack of political commitment. Without adequate domestic financing, declarations on health security are rendered ineffective.
Pathways to Solutions
To bridge the gap, several actions are crucial. National essential diagnostics lists must be implemented with investments in supply chains, training, and procurement. Integrated testing at primary health levels for fever syndromes and other conditions is technologically feasible but lacks consistent deployment.
The fragmented regulatory landscape poses a silent barrier. The African Medicines Agency, now operational, holds potential to harmonize access to quality diagnostics across member states. Prioritizing in vitro diagnostics and accelerating initiatives like Africa CDC's Diagnostic Advisory Committee can streamline processes.
Market fragmentation, with 55 different procurement systems, hinders local manufacturing. Pooled procurement under frameworks like AfCFTA can create demand certainty, incentivizing investment. Additionally, health financing must be treated as an emergency, with governments increasing budgets and exploring mechanisms like health levies and sovereign funds to reduce aid dependency.
A Call for Immediate Action
Africa's diagnostics crisis is not impending; it has persisted for generations. Continental structures, such as the Global Diagnostics Coalition, offer coherence, but progress hinges on aligning political will with industrial goals. The mother waiting for a test at a clinic symbolizes the urgent need to transform ambitions from the Lusaka Agenda and other declarations into real-world diagnostics. Africa has waited long enough; it is time for decisive action to ensure health sovereignty becomes a lived reality for all.
